169 related articles for article (PubMed ID: 31110720)
1. Toxoplasmosis as a cause of life-threatening respiratory distress in a dog receiving immunosuppressive therapy.
Pepper A; Mansfield C; Stent A; Johnstone T
Clin Case Rep; 2019 May; 7(5):942-948. PubMed ID: 31110720
[TBL] [Abstract][Full Text] [Related]
2. Acute respiratory distress syndrome and septic shock in a cat with disseminated toxoplasmosis.
Evans NA; Walker JM; Manchester AC; Bach JF
J Vet Emerg Crit Care (San Antonio); 2017 Jul; 27(4):472-478. PubMed ID: 28561960
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous nocardiosis in two dogs receiving ciclosporin therapy for the management of canine atopic dermatitis.
Siak MK; Burrows AK
Vet Dermatol; 2013 Aug; 24(4):453-6, e102-3. PubMed ID: 23781943
[TBL] [Abstract][Full Text] [Related]
4. Acute toxoplasmosis following renal transplantation in three cats and a dog.
Bernsteen L; Gregory CR; Aronson LR; Lirtzman RA; Brummer DG
J Am Vet Med Assoc; 1999 Oct; 215(8):1123-6. PubMed ID: 10530326
[TBL] [Abstract][Full Text] [Related]
5. [Toxoplasmosis after immunosuppressive therapy--our experience].
Rusináková Z; Raida L; Faber E; Tomková J; Bednaríková J; Indrák K; Novotný D
Klin Mikrobiol Infekc Lek; 2009 Jun; 15(3):95-8. PubMed ID: 19637140
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous manifestations of disseminated toxoplasmosis in an immunosuppressed dog.
Webb JA; Keller SL; Southorn EP; Armstrong J; Allen DG; Peregrine AS; Dubey JP
J Am Anim Hosp Assoc; 2005; 41(3):198-202. PubMed ID: 15870255
[TBL] [Abstract][Full Text] [Related]
7. Opportunistic Invasive Cutaneous Fungal Infections Associated with Administration of Cyclosporine to Dogs with Immune-mediated Disease.
McAtee BB; Cummings KJ; Cook AK; Lidbury JA; Heseltine JC; Willard MD
J Vet Intern Med; 2017 Nov; 31(6):1724-1729. PubMed ID: 28887897
[TBL] [Abstract][Full Text] [Related]
8. Toxoplasma gondii-associated cholecystitis in a cat receiving immunosuppressive treatment.
Lo Piccolo F; Busch K; Palić J; Geisen V; Hartmann K; Unterer S
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2019 Dec; 47(6):453-457. PubMed ID: 31814094
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of responses to immunosuppressive therapy in dogs with suspected non-regenerative immune-mediated anaemia: 11 cases (2012-2018).
Morishita K; Sugawara-Suda M; Yamazaki J; Sasaki N; Nakamura K; Ohta H; Takiguchi M
J Small Anim Pract; 2023 Aug; 64(8):527-534. PubMed ID: 37029490
[TBL] [Abstract][Full Text] [Related]
10. A rare case of acute toxoplasmosis in a stray dog due to infection of T. gondii clonal type I: public health concern in urban settings with stray animals?
Migliore S; La Marca S; Stabile C; Di Marco Lo Presti V; Vitale M
BMC Vet Res; 2017 Aug; 13(1):249. PubMed ID: 28818085
[TBL] [Abstract][Full Text] [Related]
11. Acute exacerbation of pulmonary toxoplasmosis during corticosteroid therapy for immune thrombocytopenia: A case report and literature review.
Omori K; Imoto N; Norose K; Maeda M; Hikosaka K; Kurahashi S
Medicine (Baltimore); 2021 Dec; 100(51):e28430. PubMed ID: 34941194
[TBL] [Abstract][Full Text] [Related]
12. Excessive Cyclosporine-Associated Immunosuppression in a Dog Heterozygous for the MDR1 (ABCB1-1Δ) Mutation.
Mackin AJ; Riggs C; Beatty T; Mealey K; Boothe D; Archer T
J Am Anim Hosp Assoc; 2020; 56(3):190. PubMed ID: 32182109
[No Abstract] [Full Text] [Related]
13. Interleukin-2 and interferon-gamma mRNA expression in canine anal furunculosis lesions and the effect of ciclosporin therapy.
Tivers MS; Catchpole B; Gregory SP; House AK
Vet Immunol Immunopathol; 2008 Sep; 125(1-2):31-6. PubMed ID: 18541310
[TBL] [Abstract][Full Text] [Related]
14. A suspected case of a multiple autoimmune syndrome in a poodle dog.
Lim D; Jin Y; Son Y; Oh T; Bae S
Vet Med Sci; 2022 Mar; 8(2):431-436. PubMed ID: 35137556
[TBL] [Abstract][Full Text] [Related]
15. Ehrlichia canis in dogs experimentally infected, treated, and then immune suppressed during the acute or subclinical phases.
Sato M; Veir JK; Shropshire SB; Lappin MR
J Vet Intern Med; 2020 May; 34(3):1214-1221. PubMed ID: 32267035
[TBL] [Abstract][Full Text] [Related]
16. Effect of immunosuppressive drug regimens on acute and chronic murine toxoplasmosis.
Sumyuen MH; Garin YJ; Derouin F
Parasitol Res; 1996; 82(8):681-6. PubMed ID: 8897501
[TBL] [Abstract][Full Text] [Related]
17. Antemortem diagnosis and treatment of toxoplasmosis in two cats on cyclosporin therapy.
Barrs VR; Martin P; Beatty JA
Aust Vet J; 2006; 84(1-2):30-5. PubMed ID: 16498831
[TBL] [Abstract][Full Text] [Related]
18.
Blaga R; Fabres V; Leynaud V; Fontaine JJ; Reyes-Gomez E; Briand A; Crosaz O; Lagrange I; Blaizot A; Roux DL; Castillo VR; Maksimov P; Guillot J; Teifke JP; Schares G
Pathogens; 2023 Jan; 12(1):. PubMed ID: 36678462
[TBL] [Abstract][Full Text] [Related]
19. Use of a multiplex polymerase chain reaction assay in the antemortem diagnosis of toxoplasmosis and neosporosis in the central nervous system of cats and dogs.
Schatzberg SJ; Haley NJ; Barr SC; deLahunta A; Olby N; Munana K; Sharp NJ
Am J Vet Res; 2003 Dec; 64(12):1507-13. PubMed ID: 14672429
[TBL] [Abstract][Full Text] [Related]
20. Repeated oral dose tolerance in dogs treated concomitantly with ciclosporin and oclacitinib for three weeks.
Panteri A; Strehlau G; Helbig R; Prost C; Doucette K
Vet Dermatol; 2016 Feb; 27(1):22-e7. PubMed ID: 26660461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
